Skip to main content

Typical Ablation Sites for Arrhythmias

Typical Sites for Radiofrequency Ablation of Common Cardiac Arrhythmias

Radiofrequency catheter ablation (RFA) has become a cornerstone therapy in modern cardiac electrophysiology. By delivering controlled thermal energy to specific myocardial tissue, RFA eliminates arrhythmogenic foci or interrupts abnormal conduction pathways responsible for tachyarrhythmias.


Understanding the typical anatomical targets for ablation is essential for electrophysiologists, cardiology trainees, and clinicians managing arrhythmia patients.



---


1. Atrioventricular Nodal Reentrant Tachycardia (AVNRT)


Typical Ablation Site:

Posterior septal region of the right atrium targeting the slow pathway.


Anatomical Location


Inferior part of the Triangle of Koch


Near the coronary sinus ostium


Between the tricuspid annulus and CS ostium



Rationale


AVNRT is usually caused by dual AV nodal pathways.


Ablation of the slow pathway interrupts the reentrant circuit while preserving AV nodal conduction.



Key Point Slow pathway modification has a success rate >95% with a very low risk of complete AV block.



---


2. Atrioventricular Reentrant Tachycardia (AVRT) – Accessory Pathways


Typical Ablation Site:

Along the atrioventricular annulus, where the accessory pathway connects atrium and ventricle.


Common Locations


Left-sided pathways (most common)


Left lateral mitral annulus


Left posterolateral annulus



Right-sided pathways


Right free wall tricuspid annulus



Septal pathways


Posteroseptal region


Anteroseptal region near His bundle



Approach


Left-sided pathways usually accessed via transseptal or retrograde aortic approach.



Key Point Accessory pathway ablation has a success rate >95%.



---


3. Typical Atrial Flutter


Typical Ablation Site:

Cavotricuspid Isthmus (CTI)


Anatomical Location


Region between the tricuspid annulus and inferior vena cava



Mechanism Typical atrial flutter is a macroreentrant circuit around the tricuspid annulus.


Ablation Strategy Creation of a linear ablation line across the CTI to achieve bidirectional conduction block.


Key Point CTI ablation is considered the gold standard therapy for typical atrial flutter.



---


4. Focal Atrial Tachycardia


Typical Ablation Sites


Right atrium


Crista terminalis (most common RA site)


Tricuspid annulus


Coronary sinus ostium



Left atrium


Pulmonary veins


Mitral annulus


Left atrial appendage



Mechanism


Enhanced automaticity


Triggered activity


Micro-reentry



Key Point Electroanatomic mapping is essential to identify the earliest activation site.



---


5. Atrial Fibrillation


Typical Ablation Site:

Pulmonary vein ostia / pulmonary vein antrum


Mechanism AF is commonly triggered by ectopic activity from pulmonary vein myocardial sleeves.


Ablation Strategy Pulmonary vein isolation (PVI)


Circumferential lesions around pulmonary veins


Electrical isolation from the left atrium



Additional Targets (in persistent AF)


Posterior left atrial wall


Left atrial roof lines


Mitral isthmus



Key Point Pulmonary vein isolation is the foundation of AF ablation.



---


6. Idiopathic Ventricular Tachycardia


Right Ventricular Outflow Tract (RVOT) VT


Typical Ablation Site


RVOT septum or free wall



Characteristics


Common in structurally normal hearts


Often triggered by catecholamines




---


Left Ventricular Outflow Tract (LVOT) VT


Typical Sites


Aortic cusps


LVOT septum


Aorto-mitral continuity




---


Fascicular VT


Typical Ablation Site


Left posterior fascicle of the Purkinje system



Location


Posterior septum of the left ventricle




---


7. Premature Ventricular Complexes (PVCs)


Common ablation targets include:


Right Ventricular Outflow Tract


Most frequent origin of idiopathic PVCs.


Left Ventricular Outflow Tract


Includes:


Aortic sinus cusps


Aorto-mitral continuity



Papillary Muscles


Anterolateral papillary muscle


Posteromedial papillary muscle



Moderator Band


Rare but important PVC origin.



---


Summary Table


Arrhythmia Typical Ablation Site


AVNRT Slow pathway near CS ostium

AVRT AV annulus at accessory pathway

Typical Atrial Flutter Cavotricuspid isthmus

Atrial Tachycardia Crista terminalis, PVs, annuli

Atrial Fibrillation Pulmonary vein antrum

RVOT VT RV outflow tract

Fascicular VT Left posterior fascicle

PVCs RVOT, LVOT, papillary muscles




---


Clinical Perspective


Successful catheter ablation requires precise mapping of arrhythmogenic substrates combined with a deep understanding of cardiac anatomy. Advances in 3D electroanatomic mapping, intracardiac echocardiography, and high-density mapping systems have significantly improved procedural success and safety.


Today, RFA is considered first-line therapy for many supraventricular tachycardias and selected ventricular arrhythmias, offering durable cure and improved quality of life for patients.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...